First Time Loading...

Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 15.04 CHF -0.4% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one MEDX stock under the Base Case scenario is 28.16 CHF. Compared to the current market price of 15.04 CHF, Medmix Ltd is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDX Relative Value
Base Case
28.16 CHF
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
82
vs Industry
61
Median 3Y
1.6
Median 5Y
1.6
Industry
2.4
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
6
Median 3Y
22.6
Median 5Y
22.6
Industry
23.2
Forward
31.2
More Details
16.8
P/OCF
P/OCF
Price to OCF
16.8
vs History
41
vs Industry
25
Median 3Y
15.5
Median 5Y
15.5
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
-17.9
Median 5Y
-17.9
Industry
23.5
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
91
vs Industry
58
Median 3Y
1.7
Median 5Y
1.7
Industry
2.2
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
67
vs Industry
55
Median 3Y
1.8
Median 5Y
1.8
Industry
2.5
Forward
1.6
More Details
4.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.8
vs History
55
vs Industry
46
Median 3Y
5
Median 5Y
5
Industry
5.2
More Details
10.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.3
vs History
44
vs Industry
33
Median 3Y
9.4
Median 5Y
9.4
Industry
12.5
Forward
9.1
More Details
33.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
33.4
vs History
29
vs Industry
12
Median 3Y
19.3
Median 5Y
19.3
Industry
17.2
Forward
23.1
More Details
21.1
EV/OCF
EV/OCF
Enterprise Value to OCF
21.1
vs History
32
vs Industry
21
Median 3Y
15.9
Median 5Y
15.9
Industry
15.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
5
Median 3Y
21.5
Median 5Y
21.5
Industry
19.7
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
79
vs Industry
59
Median 3Y
1.2
Median 5Y
1.2
Industry
2
More Details

Multiples Across Competitors

MEDX Competitors Multiples
Medmix Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Medmix Ltd
SIX:MEDX
617.2m CHF 1.3 -125.5 10.3 33.4
US
Abbott Laboratories
NYSE:ABT
183B USD 4.5 32.4 19.2 28.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
131.6B USD 18 66.4 54.3 68.1
US
Stryker Corp
NYSE:SYK
123.8B USD 6 37.1 24.1 29.7
IE
Medtronic PLC
NYSE:MDT
107.8B USD 3.3 25.6 13.7 19.3
US
Boston Scientific Corp
NYSE:BSX
104.8B USD 7.2 59.9 30.6 45.1
US
Becton Dickinson and Co
NYSE:BDX
68.9B USD 3.5 56.5 18.9 39.9
DE
Siemens Healthineers AG
XETRA:SHL
57.2B EUR 2.6 37.7 18.2 30.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Edwards Lifesciences Corp
NYSE:EW
51.1B USD 8.3 35.9 26.1 28.2
US
Dexcom Inc
NASDAQ:DXCM
49.6B USD 13.1 78 58.3 75.9

See Also

Summary
MEDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDX stock valuation using valuation multiples.
Wall Street Estimates
MEDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.